Latest news

Search
Categories
News archive

The Production of NLAB Saga® Stabilizes 

18 June, 2024

Nanologica has now approved a number of normal-sized batches from the large-scale production of the company’s silica for preparative chromatography, NLAB Saga®. Scaling up to large-scale production of silica at the contract manufacturer Sterling Pharma Solutions has been fraught with several challenges such as loss of material, which has previously been communicated. Although a couple of challenges remain, the company has now for the first time completed several large production batches in a row, which

Read more »

Bulletin from the AGM in Nanologica

16 May, 2024

Nanologica AB (publ) today 16 May 2024 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted. Adoption of the income statement and balance sheet, disposition of result The Annual General Meeting adopted the income statement and balance sheet for the company and the group in accordance with the presented accounting documents and resolved, in accordance with the board´s proposal, that the accumulated loss of SEK -75,880,232 shall be carried forward.

Read more »

CEO Comment Q1 2024

26 April, 2024

The year has started both positively and negatively. On a positive note, we have started delivering chromatography media to customers and we achieved net sales of MSEK 5 in the first quarter. This is the company’s highest sales of chromatography products in a single quarter to date and in line with the expectations of a a sharp increase in sales of chromatography media in 2024. At the same time, the work of optimizing the production

Read more »